Skip to Main Content

News & Events

Latest News from VACS

  • Amid Opioid Overdose Crisis, Yale Program in Addiction Medicine Advises State on Drug Company Settlement Spending

    The majority of the estimated $206 billion resulting from the Tobacco Master Settlement Agreement have not gone to address smoking or public health. Following a similar settlement of a multi-state litigation, the state of Connecticut is expecting around $600 million to address the state’s opioid overdose crisis, which resulted in 1,340 overdose deaths in 2023 alone. To avoid the experience of the Tobacco funds, Yale faculty are proactively providing recommendations on how to spend these funds.

    Read more
  • Excess Deaths During the COVID-19 Pandemic

    Most analyses regarding the excess risk of death during the COVID-19 pandemic have relied on summary data. However, a recent study published in the International Journal of Epidemiology instead analyzed individual patient-level data based on medical records from the largest integrated healthcare system in the United States.

    Read more
  • Prostate cancer diagnosed later in US men with HIV

    Professor Keith Sigel of Icahn School of Medicine at Mount Sinai Hospital, New York, reported on a study of prostate cancer diagnoses and outcomes in the Veterans Aging Cohort Study. Using medical records and cancer registries, they compared cancer stage at diagnosis, survival after diagnosis and testing for prostate-specific antigen (PSA) prior to diagnosis in men with and without HIV.

    Source: AIDSMap
    Read more
  • Prostate Cancer Treatment Guided By New Tool

    According to the Centers for Disease Control and Prevention, cancer is a leading cause of death in the United States. Unfortunately for American men, prostate cancer remains one of the deadliest cancers. The Veterans Aging Cohort Study (VACS) Consortium sought to give physicians and other medical professionals guidance on how to determine treatment in patients with prostate cancer.

    Read more
  • VA/Yale Researchers Lead Multi-ancestry Study of Genetics of Problematic Alcohol Use

    A study led by VA Connecticut Healthcare Center/Yale researchers reveals ancestries around the world possess a shared genetic architecture for problematic alcohol use – habitual heavy drinking, accompanied by harmful consequences. Hang Zhou, PhD, assistant professor of psychiatry and of biomedical informatics & data science at Yale School of Medicine and VA Connecticut, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, and professor of genetics and of neuroscience at Yale School of Medicine and VA Connecticut, were first and senior authors, respectively.

    Read more
  • Alcohol Research Conference Fosters Collaboration Across Specialties

    Now in its second year, the Yale Conference for Alcohol Research and Education (YCARE) was held on September 30, 2023. Offering a comprehensive agenda of talks, panel discussions, and poster presentations, the all-day event brought together Yale's researchers, clinicians, and other stakeholders under the banner of alcohol research. Bubu Banini, MD, PhD, assistant professor of medicine (digestive diseases), Yale School of Medicine (YSM), spearheaded the conference, along with co-directors David Fiellin, MD, professor of medicine (general medicine) and emergency medicine, YSM, and public health, Yale School of Public Health; Graeme Mason, PhD, professor of radiology and biomedical imaging and of psychiatry, YSM; and Sherry McKee, PhD, professor of psychiatry, YSM.

    Read more
Get RSS Feed